Research, and its integration from basic biology discovery to bidirectional translational science, forms the pillars required to achieve better care for cancer patients. Being part of the process to fund truly impactful research that leads to game-changing treatments is exceptionally rewarding.”
As Scientific Director of the Cell Biology and Preclinical Cancer Research program in the Extramural Discovery Sciences department of the American Cancer Society (ACS), Paul Campbell, PhD, oversees peer review and grants management in areas related to all aspects of cancer cell biology, tumor microenvironment, experimental therapeutics, and translational science.
Prior to joining ACS, Campbell, PhD, was an Assistant Professor in the Cancer Signaling and Microenvironment Program and The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center (FCCC), where he directed a cancer research program investigating the intersection of oncogene signaling and tumor microenvironment in pancreatic adenocarcinoma.
His studies have employed basic molecular and cellular biology techniques and clinical-translational research to elucidate the intra- and intercellular signaling that governs cancer progression.
Campbell has served on several grant review study sections including the Department of Defense and ACS. Having developed courses in the Department of Pharmacology & Physiology at Drexel University College of Medicine, serving as Co-Director for FCCC’s Trainee Seminar Series, and acted as laboratory mentor or graduate thesis committee member for 50 trainees, Campbell is committed to supporting the next generation of research and clinician scientists.
For a full list of Dr. Campbell's publications, visit his MyBibliography page.
I enjoy cycling and yoga, and live in Philadelphia, PA.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.